Physician profile
Cory Harris
NPI 1629232244
$1,389.90
in general payments reported to CMS, 2019-2025
16 companies · $594 in 2025
The $594 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $29.60 · 2021: $173 · 2022: $144 · 2023: $114 · 2024: $214 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $271.07 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $249.10 | 2022-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $192.99 | 2019-2022 | |
| Procept Biorobotics Corporation | $132.52 | 2021 | |
| Ferring Pharmaceuticals INC. | $112.32 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $81.09 | 2022-2025 | |
| Pfizer INC. | $77.49 | 2024-2025 | |
| Myovant Sciences INC. | $53.40 | 2022 | |
| Axonics, INC. | $45.54 | 2023-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $29.42 | 2024 | Interstim |
| 180 Medical, INC. | $29.38 | 2024 | Gentlecath Glide |
| Tempus Ai, INC | $27.03 | 2025 | Xt Cdx |
| Endo USA, INC. | $26.11 | 2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $23.42 | 2023 | Veozah |
| Urovant Sciences INC | $22.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.